Form 4 for NXDT NEXPOINT DIVERSIFIED REAL ESTATE TRUST
Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-01 · accession 0001437749-23-021968 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-08-03 | 2023-08-01 | NXDT | DONDERO JAMES D | See Remarks, Dir, 10% | J - Other | — | +14.6K | 288.5K | +5% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-01 | J | A | 7,780.44 | — | 281,701.22 | I See Footnote | — | — | (F1) Under the terms of the Advisory Agreement, dated July 1, 2022, by and between NexPoint Diversified Real Estate Trust (the "Company") and NexPoint Real Estate Advisers X, L.P. (the "Adviser"), as amended by that First Amendment to Advisory Agreement dated October 25, 2022, and as amended by that Second Amendment to Advisory Agreement, dated April 11, 2023 (the "Advisory Agreement"), the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the volume-weighted average price ("VWAP") of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 7,780.44 common shares to the Adviser as payment of its fees for the month of May at a VWAP of $10.057 per share. (F2) 31,556 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 66,584.78 shares are held by PCMG Trading Partners XXIII, L.P., 175,780 shares are held by Governance Re Ltd. and 14,588.75 are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2023-08-01 | J | A | 6,808.31 | — | 288,509.53 | I See Footnote | — | — | (F3) Under the terms of the Advisory Agreement, the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the VWAP of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 6,808.31 common shares to the Adviser as payment of its fees for the month of June at a VWAP of $11.493 per share. (F2) 31,556 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 66,584.78 shares are held by PCMG Trading Partners XXIII, L.P., 175,780 shares are held by Governance Re Ltd. and 14,588.75 are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |